期刊文献+

尿毒症合并DebakeyⅡ型主动脉夹层手术治疗并肾移植术个案分析

Case analysis on a patient suffering with uremia complicated with Debakey typeⅡaortic dissection and receiving surgical treatment and kidney transplant
下载PDF
导出
摘要 目的探讨尿毒症患者合并主动脉夹层(AD)的原因及手术治疗后并行肾移植临床治疗情况。方法通过1例病例资料分析了尿毒症合并DebakeyⅡ型主动脉夹层的手术治疗并肾移植术情况进行分析。结果本例尿毒症合并DebakeyⅡ型AD患者行手术治疗并肾移植术,术后恢复良好,并继续规律行血液透析治疗,随访期间病情均稳定,血尿常规、肝肾功能均恢复正常。结论尿毒症合并AD时,其临床症状、体征可不典型,易误漏诊,临床医生尤其要重视,可行超声及胸腹主动脉血管造影检查鉴别;其行肾移植术,围手术期心脑血管风险大,血管吻合技术要求高,增加肾移植手术的风险和难度。 Objective To investigate the causes of uremic patients with aortic dissection(AD)and the clinical treatment of renal transplantation after surgical treatment.Methods The conditions of surgical treatment and kidney transplant for a patient with uremia complicated with DebakeyⅡaortic dissection were analyzed through the analysis on the case data.Results This case of uremia complicated with Debakey typeⅡaortic dissection underwent surgery and renal transplantation.The postoperative recovery was good,and the hemodialysis treatment was continued regularly.During the follow-up period,the condition was stable,and the routine blood and urine,liver and kidney functions returned to normal.Conclusions When uremia complicated with AD,its clinical symptoms and signs can be atypical and easy to be misdiagnosed.Clinicians should pay special attention to it,which could be differentiated by ultrasound and thoracoabdominal aortic angiography.The perioperative cardiovascular and cerebrovascular risk is high,and the technical requirements of vascular anastomosis are high,which increases the risk and difficulty of renal transplantation.
作者 吴淑芳 林丹华 徐海山 Wu Shufang;Lin Danhua;Xu Haishan(Affiliated hospital of of Putian University,Putian,Fujian,351100,China)
出处 《齐齐哈尔医学院学报》 2022年第3期229-230,共2页 Journal of Qiqihar Medical University
关键词 尿毒症 DebakeyⅡ型 主动脉夹层 肾移植 Uremia DebakeyⅡtype Aortic dissection Renal transplantation
  • 相关文献

参考文献2

二级参考文献26

  • 1张瑞岩,沈卫峰.慢性肾病与心血管疾病[J].中国循环杂志,2004,19(3):234-235. 被引量:7
  • 2Covic A, Goldsmith D. Ambulatory blood pressure monitoring: an essential tool for blood pressure assessment in uremic patients [J]. Nephrol Dial Transplant,2002,17(10):1737-1741.
  • 3Coresh J, Wei GL, McQuillan G, et al. Prevalence of high blood pressure and elevated serum creatinine level in the United States: findings from the third National Health and Nutrition Examination Survey (1988- 1994)[J]. Arch Intern Med, 2001,161 (9) : 1207-1216.
  • 4K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Kidney disease outcome quality initiative 2002[J]. Am J Kid Dis,2002,39(suppl 2) : 7-10.
  • 5Lunde P, Baksaas I, Halse M, etal. The methodology of drug utilization studies. In: studies in drug utilization: WHO regional office for Europe-bergman U, Grimsson A, Wahba A, Werterholm B, eds. Copenhague. WHO Regional Office for Europe, 1997:17-28.
  • 6Maarten WT. Slowing the progression of adult chronic kidney disease[J]. Drugs, 2004,4 (20): 2273-2289.
  • 7Anil KB, Karen AG. Pathophysiology of hypertensive renal damage: implications for therapy[J]. Hypertension,2004,44(5):595- 601.
  • 8Muntner P, Anderson A, Charleston J, etal. Hypertension awareness, treatment, and control in adults with CKD: results from the Chronic Renal Insufficiency Cohort (CRIC) Study[J]. Am J Kidney Dis,2010,55(3):441-451.
  • 9Wang Y, Zhang L, Li X, et al. Improvement of awareness, treatment and control of hypertension among chronic kidney disease patients in China from 1999 to 2005[J]. Hypertens Res, 2009,32(6) :444-449.
  • 10Cheng LT, Gao YL, Gu Y, etal. Stepwise increase in the prevalence of isolated systolic hypertension with the stages of chronic kidney disease[J]. Nephrol Dial Transplant, 2008,23 (12) : 3895- 3900.

共引文献42

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部